UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Endocannabinoids Activate Transient Receptor Potential Vanilloid 1 Receptors to Reduce Hyperdopaminergia-Related Hyperactivity: Therapeutic Implications

Biological psychiatry (1969), 2006-03, Vol.59 (6), p.508-515

2006

Volltextzugriff (PDF)

5-HT1F Receptor Agonists in Acute Migraine Treatment: A Hypothesis

Cephalalgia, 2003-10, Vol.23 (8), p.776-785

2003

Volltextzugriff (PDF)

Neurogenic Dural Protein Extravasation Induced by Meta-Chlorophenylpiperazine (Mcpp) Involves Nitric Oxide and 5-HT2B Receptor Activation

Cephalalgia, 2003-03, Vol.23 (2), p.117-123

2003

Volltextzugriff (PDF)

Minocycline Prevents Nigrostriatal Dopaminergic Neurodegeneration in the MPTP Model of Parkinson's Disease

Proceedings of the National Academy of Sciences - PNAS, 2001-12, Vol.98 (25), p.14669-14674

2001

Volltextzugriff (PDF)

Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: Dopamine D2, serotonin 2A and NK-1 receptors as examples

Life sciences (1973), 2005-12, Vol.78 (4), p.340-346

2005

Volltextzugriff (PDF)

The PET Radioligand [11C]MePPEP Binds Reversibly and with High Specific Signal to Cannabinoid CB1 Receptors in Nonhuman Primate Brain

Neuropsychopharmacology (New York, N.Y.), 2008-01, Vol.33 (2), p.259-269

2008

Volltextzugriff (PDF)

Selective seratonin 1F (5-HT 1F) receptor agonist LY334370 for acute migraine: a randomised controlled trial

The Lancet (British edition), 2001-10, Vol.358 (9289), p.1230-1234

2001

Volltextzugriff (PDF)

LY293558, a Novel AMPA/GluR5 Antagonist, is Efficacious and Well-Tolerated in Acute Migraine

Cephalalgia, 2004-07, Vol.24 (7), p.596-602

2004

Volltextzugriff (PDF)

The non-peptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigs

Life sciences (1973), 1997-03, Vol.60 (18), p.1553-1561

1997

Volltextzugriff (PDF)

Chronic coadministration of olanzapine and fluoxetine activates locus coeruleus neurons in rats : implications for bipolar disorder

Psychopharmacologia, 2005-08, Vol.181 (1), p.126-133

2005

Volltextzugriff (PDF)

The relationship of in vivo central CB1 receptor occupancy to changes in cortical monoamine release and feeding elicited by CB1 receptor antagonists in rats

Psychopharmacologia, 2006, Vol.184 (1), p.26-35

2006

Volltextzugriff (PDF)

Measurement of striatal H2O2 by microdialysis following global forebrain ischemia and reperfusion in the rat : correlation with the cytotoxic potential of H2O2 in vitro

Brain research, 1995-02, Vol.671 (2), p.181-186

1995

Volltextzugriff (PDF)

Fluoxetine administration potentiates the effect of olanzapine on locus coeruleus neuronal activity

Biological psychiatry (1969), 2004-06, Vol.55 (11), p.1103-1109

2004

Volltextzugriff (PDF)

Lanepitant, an NK-1 Antagonist, in Migraine Prevention

Cephalalgia, 2001-03, Vol.21 (2), p.102-106

2001

Volltextzugriff (PDF)

5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs

Neuroreport, 1997-07, Vol.8 (9), p.2237-2239

1997

Volltextzugriff (PDF)

Ethyl (3S,4aR,6S,8aR)-6-(4-Ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso- quinoline-3-carboxylic Ester: A Prodrug of a GluR5 Kainate Receptor Antagonist Active in Two Animal Models of Acute Migraine

Journal of medicinal chemistry, 2002-09, Vol.45 (20), p.4383-4386

2002

Volltextzugriff (PDF)

Novel Potent 5-HT1F Receptor Agonists: Structure−Activity Studies of a Series of Substituted N-[3-(1-Methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides

Journal of medicinal chemistry, 2003-07, Vol.46 (14), p.3060-3071

2003

Volltextzugriff (PDF)

Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine

Life sciences (1973), 1997-10, Vol.61 (21), p.2117-2126

1997

Volltextzugriff (PDF)

Serotonin in migraine: theories, animal models and emerging therapies

Progress in drug research, 1998, Vol.51, p.219

1998

Volltextzugriff (PDF)

N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: A Potent, Selective, and Orally Active 5-HT1F Receptor Agonist Potentially Useful for Migraine Therapy

Journal of medicinal chemistry, 2001-11, Vol.44 (24), p.4031-4034

2001

Volltextzugriff (PDF)

5-HT 1F Receptor Agonists in Acute Migraine Treatment: A Hypothesis

Cephalalgia, 2003-10, Vol.23 (8), p.776-785

2003

Volltextzugriff (PDF)

Dopamine depletion protects striatal neurons from ischemia-induced cell death

Life sciences (1973), 1988, Vol.42 (6), p.707-713

1988

Volltextzugriff (PDF)

Human 5-HT1F receptor-stimulated [35S]GTPγS binding: correlation with inhibition of guinea pig dural plasma protein extravasation

European journal of pharmacology, 1998-07, Vol.352 (1), p.117-124

1998

Volltextzugriff (PDF)

The antioxidant LY231617 reduces global ischemic neuronal injury in rats

Stroke (1970), 1993-05, Vol.24 (5), p.716-722

1993

Volltextzugriff (PDF)

A fluorescence-based method for assessing dural protein extravasation induced by trigeminal ganglion stimulation

Journal of neuroscience methods, 1998-06, Vol.81 (1), p.19-24

1998

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Endocannabinoids Activate Transient Receptor Potential Vanilloid 1 Receptors to Reduce Hyperdopaminergia-Related Hyperactivity: Therapeutic Implications

5-HT1F Receptor Agonists in Acute Migraine Treatment: A Hypothesis

Neurogenic Dural Protein Extravasation Induced by Meta-Chlorophenylpiperazine (Mcpp) Involves Nitric Oxide and 5-HT2B Receptor Activation

Minocycline Prevents Nigrostriatal Dopaminergic Neurodegeneration in the MPTP Model of Parkinson's Disease

Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: Dopamine D2, serotonin 2A and NK-1 receptors as examples

The PET Radioligand [11C]MePPEP Binds Reversibly and with High Specific Signal to Cannabinoid CB1 Receptors in Nonhuman Primate Brain

Selective seratonin 1F (5-HT 1F) receptor agonist LY334370 for acute migraine: a randomised controlled trial

LY293558, a Novel AMPA/GluR5 Antagonist, is Efficacious and Well-Tolerated in Acute Migraine

The non-peptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigs

Chronic coadministration of olanzapine and fluoxetine activates locus coeruleus neurons in rats : implications for bipolar disorder

The relationship of in vivo central CB1 receptor occupancy to changes in cortical monoamine release and feeding elicited by CB1 receptor antagonists in rats

Measurement of striatal H2O2 by microdialysis following global forebrain ischemia and reperfusion in the rat : correlation with the cytotoxic potential of H2O2 in vitro

Fluoxetine administration potentiates the effect of olanzapine on locus coeruleus neuronal activity

Lanepitant, an NK-1 Antagonist, in Migraine Prevention

5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs

Ethyl (3S,4aR,6S,8aR)-6-(4-Ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso- quinoline-3-carboxylic Ester: A Prodrug of a GluR5 Kainate Receptor Antagonist Active in Two Animal Models of Acute Migraine

Novel Potent 5-HT1F Receptor Agonists: Structure−Activity Studies of a Series of Substituted N-[3-(1-Methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides

Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine

Serotonin in migraine: theories, animal models and emerging therapies

N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: A Potent, Selective, and Orally Active 5-HT1F Receptor Agonist Potentially Useful for Migraine Therapy

5-HT 1F Receptor Agonists in Acute Migraine Treatment: A Hypothesis

Dopamine depletion protects striatal neurons from ischemia-induced cell death

Human 5-HT1F receptor-stimulated [35S]GTPγS binding: correlation with inhibition of guinea pig dural plasma protein extravasation

The antioxidant LY231617 reduces global ischemic neuronal injury in rats

A fluorescence-based method for assessing dural protein extravasation induced by trigeminal ganglion stimulation

Suchergebnisse filtern